Michael J. Fox Foundation Commits Up To $3.8 Million To Develop Gene Silencing Neuroprotective Treatment For Parkinson’s Disease
The Michael J. Fox Foundation has committed up to $3.8 million for the development of a gene silencing therapeutic to treat Parkinson’s disease by reducing expression of the protein alpha-synuclein.
More: continued here
Filed under: Parkinson's Disease on January 7th, 2008